Subscribe here for new information from our diverse feeds.
Principal Investigator: Honorati Masanja
Project leader/ Coordinator: Solomon Mwakasungura
Project Administrator: Priscilla Mlay
Funding Partner: European and Developing Countries Clinical Trials Partnership Programme (EDCTP)
Start date: March 1, 2018
End date: Feb. 28, 2022
We aim to develop and enhance laboratory, public health and clinical trials capacities for the rapid investigation of outbreaks at source. Laboratories will be developed for accurate rapid detection all pathogens. Regional capacities will also be built to perform clinical trials (evaluating rapid diagnostic, biomarkers, treatments vaccines and operational research studies) inter-epidemic and during an outbreak.
Data will be used for optimal clinical management of patients, infection control and public health response. Over all aims Our overall objectives is to strengthen, regional and Pan-African capacities and systems for enabling rapid and effective response to re-emerging infectious disease threats arising from within Africa, or those imported from overseas.
We aim to build laboratory, public health and clinical trials capacity for the rapid investigation of outbreaks at source. Laboratory systems will be made capable of safely and accurately detecting all pathogens with minimal biohazard risk. Capacities will also be built to perform multi-site clinical trials (evaluating rapid diagnostics, biomarkers and a range treatments, vaccines and operational research studies) in response to emerging infectious diseases threats.
This will include obtaining accelerated evidence for optimal clinical management of patients, infection control measures, surveillance, public health response and vector control programs, during outbreaks caused by pathogens (including antimicrobial-resistant pathogens) with epidemic potential.#